News & Articles

The European specialty pharmaceutical company establishes a unified digital data foundation to enable future agentic orchestration

Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media

Novel treatment offers non-immunosuppressive approach for localized acid neutralization and calcium delivery

Researchers identify RFP protein as a key driver of fat cell formation, opening paths to future obesity treatments

Don Whitley Scientific reaches milestone showing unwavering commitment to microbiology

The American Board of Medical Specialties (ABMS) Portfolio Program will leverage Ovid Synthesis, which now features Wolters Kluwer’s Expert AI, to streamline the continuing certification credit process and fast-track patient improvement initiatives

The new subsidiary is expected to accelerate broader adoption of Seegene’s developing solutions, CURECA™ and STAgora™, in Europe

Collaboration unites complementary scientific and technical expertise to provide seamless solutions across the biopharmaceutical value chain

6,000-square-foot facility enables clinical and commercial process development support to help cell therapy developers transition from research-scale to commercialization

Myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities

Agreement to broaden access, streamline logistics, and reduce variability associated with temperature-sensitive shipping of 3D tissue models, without cryopreservation

The point-of-care test detects and differentiates between three types of Bordetella infection that can cause similar cough symptoms, ensuring patients receive the right diagnosis at the earliest opportunity

Test helps to identify patients at high risk who need intervention or closer monitoring

Partnership will strengthen UK cell and gene therapy manufacturing pathway

Expanding maintenance and support for LHS customers, and strengthening sales reach and application expertise

Collaboration aims to equip users with complete NGS solution from sample to answer

Test will serve as a companion diagnostic for Bayer’s HYRNUO™ (sevabertinib) to identify patients with non-small cell lung cancer eligible for HER2-targeted therapy

The project will generate 830 GWh of clean electricity annually, powering over 440,000 homes and reducing 166,549 tons of CO₂ emissions

New generation of allergen tests to support faster, more accurate diagnosis worldwide

Felicity Solar joins ENF Trade TV discussion on LFP vs sodium-ion batteries amid global energy storage surge

A study from Karl Landsteiner University of Health Sciences demonstrates HIFU effectively controls prostate cancer and maintains patients’ quality of life.